Madách Krisztina, Molvarec Attila, Rigó János, Nagy Bálint, Pénzes István, Karádi István, Prohászka Zoltán
Department of Anesthesiology and Intensive Therapy, Semmelweis University, Budapest, Hungary.
Eur J Obstet Gynecol Reprod Biol. 2008 Aug;139(2):133-8. doi: 10.1016/j.ejogrb.2007.12.012. Epub 2008 Feb 4.
We have recently demonstrated that serum 70 kDa heat shock protein (Hsp70) levels are increased in the syndrome of hemolysis, elevated liver enzymes, and low platelet count (HELLP syndrome). The aim of the present study was to investigate in an independent, larger cohort of patients whether serum Hsp70 levels are related to laboratory markers of HELLP syndrome.
The study population included 14 patients with HELLP syndrome. Serum Hsp70 levels were measured by enzyme-linked immunosorbent assay. The relationship between serum Hsp70 levels and laboratory markers of hemolysis, hepatocellular damage, renal insufficiency, inflammation or disseminated intravascular coagulation (DIC), as well as platelet count was investigated by calculating correlation coefficients, standardized regression coefficients and by principal component analysis.
Serum Hsp70 levels showed a very strong correlation to the markers of hemolysis (plasma free hemoglobin level, serum lactate dehydrogenase activity, and total bilirubin level) and of hepatocellular injury (serum aminotransferase activities), supported also by principal component analysis. Furthermore, circulating Hsp70 concentration reflected the severity of HELLP syndrome as expressed by the significant inverse correlation to the lowest platelet count. By contrast, there was no relationship between serum Hsp70 levels and markers of inflammation, coagulation, fibrinolysis or renal insufficiency.
Elevated serum 70 kDa heat shock protein level seems to reflect tissue damage (hemolysis and hepatocellular injury) and disease severity in patients with HELLP syndrome. However, further investigations are needed to determine the clinical relevance of these findings.
我们最近证实,溶血、肝酶升高和血小板减少综合征(HELLP综合征)患者的血清70 kDa热休克蛋白(Hsp70)水平升高。本研究的目的是在一个独立的、更大的患者队列中调查血清Hsp70水平是否与HELLP综合征的实验室指标相关。
研究人群包括14例HELLP综合征患者。采用酶联免疫吸附测定法测量血清Hsp70水平。通过计算相关系数、标准化回归系数和主成分分析,研究血清Hsp70水平与溶血、肝细胞损伤、肾功能不全、炎症或弥散性血管内凝血(DIC)的实验室指标以及血小板计数之间的关系。
血清Hsp70水平与溶血指标(血浆游离血红蛋白水平、血清乳酸脱氢酶活性和总胆红素水平)和肝细胞损伤指标(血清转氨酶活性)显示出非常强的相关性,主成分分析也支持这一点。此外,循环Hsp70浓度反映了HELLP综合征的严重程度,这表现为与最低血小板计数呈显著负相关。相比之下,血清Hsp70水平与炎症、凝血、纤维蛋白溶解或肾功能不全指标之间没有关系。
血清70 kDa热休克蛋白水平升高似乎反映了HELLP综合征患者的组织损伤(溶血和肝细胞损伤)及疾病严重程度。然而,需要进一步研究来确定这些发现的临床相关性。